Biotronik announced CE approval for its new Ilivia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds), improving magnetic resonance imaging (MRI) access for cardiac device patients. Ilivia devices come with the company’s ProMRI technology, as well as MRI AutoDetect.

Medtronic announced Feb. 3 that the U.S. Food and Drug Administration (FDA) revised the CoreValve’s instructions for use ...

Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of the Resolute Onyx DES, a next-generation drug-eluting stent now available in 4.5 and 5 mm diameter sizes. The CE Mark also approved several new product indications including treatment of left main vessels and small vessels.

Agfa HealthCare announced it would be showcasing its convergence approach to enterprise imaging during the 2016 Healthcare Information and Management Systems Society annual conference (HIMSS16). The company’s Enterprise Imaging and Enterprise Content Management (ECM) platforms will be on display at the annual conference and exhibition, March 1 - 3, in Las Vegas.

The findings of a major study led by cardiovascular imaging specialists at Allegheny General Hospital (AGH) suggest magnetic resonance imaging (MRI) is a safe and effective diagnostic procedure for patients with implantable cardiac devices.

Diseased hearts may be thrown out of rhythm by structural differences, now visible for the first time, in protein groups that connect heart muscle cells, according to the authors of a study published in the journal Nature Communications online.

IBM Watson Health announced that the 2015/2016 Best in KLAS: Software & Services report recognized two of its newly acquired companies for population health and imaging solutions.

In November, following the U.S. Food and Drug Administration approval of Cook Medical’s Zenith Alpha Thoracic Endovascular Graft, the first patient was treated with the device in the United States.